Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$572M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$495M |
| 3 |
iShares MBS ETF
MBB
|
+$405M |
| 4 |
Procter & Gamble
PG
|
+$365M |
| 5 |
Microsoft
MSFT
|
+$327M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$605M |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$544M |
| 3 |
Sempra
SRE
|
+$474M |
| 4 |
CELG
Celgene Corp
CELG
|
+$411M |
| 5 |
BPL
Buckeye Partners, L.P.
BPL
|
+$380M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.85% |
| 2 | Healthcare | 5.77% |
| 3 | Financials | 5.26% |
| 4 | Consumer Discretionary | 4.71% |
| 5 | Communication Services | 4.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1551
Knight Transportation
KNX
$11.3B
| $8.22M | ﹤0.01% |
229,438
+118,410
| +107% | +$4.35M |
|
1552
PUT
Monster Beverage
MNST
$89.9B
| $8.22M | ﹤0.01% |
258,800
+160,200
| +162% | +$4.71M |
|
1553
PUT
Baxter International
BAX
$14.3B
| $8.22M | ﹤0.01% |
98,300
+90,800
| +1,211% | +$7.51M |
|
|
BZUN
1554
CALL
Baozun
BZUN
$171M
| $8.22M | ﹤0.01% |
248,100
+3,900
| +2% | +$155K |
|
1555
AGNC Investment
AGNC
$12.6B
| $8.21M | ﹤0.01% |
464,131
-247,485
| -35% | -$4.21M |
|
1556
Cousins Properties
CUZ
$4.81B
| $8.17M | ﹤0.01% |
198,382
+23,729
| +14% | +$933K |
|
|
ZNGA
1557
DELISTED
ZYNGA INC. CL A COMMON
ZNGA
| $8.17M | ﹤0.01% |
1,335,072
-886,143
| -40% | -$5.48M |
|
1558
CALL
ProShares Trust UltraShort Lehman 20+ Year Treasury
TBT
$309M
| $8.15M | ﹤0.01% |
307,000
-425,300
| -58% | -$10.9M |
|
1559
Monro
MNRO
$366M
| $8.13M | ﹤0.01% |
104,010
+47,911
| +85% | +$3.61M |
|
1560
Manulife Financial
MFC
$73B
| $8.12M | ﹤0.01% |
400,325
-45,169
| -10% | -$863K |
|
1561
PUT
C.H. Robinson
CHRW
$17.5B
| $8.12M | ﹤0.01% |
103,800
+65,600
| +172% | +$5.22M |
|
|
KYNB
1562
Kyntra Bio
KYNB
$28.7M
| $8.1M | ﹤0.01% |
7,552
+1,395
| +23% | +$1.42M |
|
1563
Takeda Pharmaceutical
TAK
$55.9B
| $8.09M | ﹤0.01% |
410,112
-24,100
| -6% | -$461K |
|
1564
Rithm Capital
RITM
$5.59B
| $8.09M | ﹤0.01% |
502,088
+137,791
| +38% | +$2.16M |
|
1565
CALL
MongoDB
MDB
$33.5B
| $8.08M | ﹤0.01% |
61,400
+46,000
| +299% | +$6.04M |
|
1566
PUT
Factset
FDS
$10.2B
| $8.08M | ﹤0.01% |
30,100
-49,100
| -62% | -$12.6M |
|
1567
PUT
Las Vegas Sands
LVS
$29.4B
| $8.07M | ﹤0.01% |
116,900
+30,000
| +35% | +$1.87M |
|
1568
Helen of Troy
HELE
$664M
| $8.07M | ﹤0.01% |
44,872
+9,602
| +27% | +$1.54M |
|
|
MOMO
1569
CALL
Hello Group
MOMO
$875M
| $8.05M | ﹤0.01% |
240,300
-142,300
| -37% | -$5.06M |
|
1570
Cheniere Energy
LNG
$54.6B
| $8.04M | ﹤0.01% |
131,751
+47,674
| +57% | +$2.93M |
|
|
1571
CALL
Cheniere Energy
LNG
$54.6B
| $8.03M | ﹤0.01% |
131,400
-52,900
| -29% | -$3.26M |
|
1572
PUT
Take-Two Interactive
TTWO
$47.2B
| $8.02M | ﹤0.01% |
65,500
-23,300
| -26% | -$2.84M |
|
1573
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
$23.3B
| $8.01M | ﹤0.01% |
149,407
+148,975
| +34,485% | +$7.99M |
|
1574
PTC Therapeutics
PTCT
$6.14B
| $8.01M | ﹤0.01% |
166,806
-121,499
| -42% | -$5.16M |
|
1575
PUT
Marvell Technology
MRVL
$192B
| $8.01M | ﹤0.01% |
301,500
+175,500
| +139% | +$4.45M |
|
Similar funds
Barclays's Q4 2019 Portfolio in Review
As of Q4 2019, Barclays held 7,254 positions worth $180B, up 13% from $160B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Barclays deployed $6.1B of net new capital in Q4 2019, opening 260 new positions and adding to 3,541 existing holdings. Its largest new stake was Pacer iPath Gold ETNs: 1,000,000 shares worth $25.3M.
By sector, the portfolio is most concentrated in Technology at 8.9% of assets, up from 7.7% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Invesco QQQ Trust, an estimated $605M trimmed.
- Barclays's largest Q4 2019 buy was Pacer iPath Gold ETNs: 1,000,000 shares worth $25.3M.
- Barclays added most to Apple in Q4 2019, an estimated $572M increase.
- Barclays's biggest Q4 2019 reduction was Invesco QQQ Trust, cutting an estimated $605M.
- Barclays fully exited Celgene Corp in Q4 2019, selling an estimated $411M.
- Barclays's ten largest holdings make up 26% of its $180B portfolio in Q4 2019.
- Barclays opened 260 new positions and closed 700 in Q4 2019.
- Barclays's portfolio value rose 13% quarter-over-quarter to $180B.
Based on Barclays's 13F filing for Q4 2019, filed 10 Feb 2020.